Intelligent Bio Solutions Inc. Files 8-K on Financials
Ticker: INBS · Form: 8-K · Filed: Aug 7, 2025 · CIK: 1725430
Sentiment: neutral
Topics: financial-reporting, 8-K, company-update
TL;DR
IBSI filed an 8-K on Aug 7, 2025, detailing financial results and exhibits.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
Why It Matters
This 8-K filing provides investors with crucial updates on the financial health and operational performance of Intelligent Bio Solutions Inc.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former Company Name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former Company Name
- August 7, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Intelligent Bio Solutions Inc., and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on August 7, 2025.
What were Intelligent Bio Solutions Inc.'s previous names?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
Where is Intelligent Bio Solutions Inc.'s principal executive office located?
Intelligent Bio Solutions Inc.'s principal executive office is located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the SIC code for Intelligent Bio Solutions Inc.?
The Standard Industrial Classification (SIC) code for Intelligent Bio Solutions Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 531 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-08-07 17:00:25
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-25-011706.txt ( ) — 220KB
- inbs-20250807.xsd (EX-101.SCH) — 3KB
- inbs-20250807_lab.xml (EX-101.LAB) — 33KB
- inbs-20250807_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 7, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer